Dohj LLC Acquires New Holdings in Zoetis Inc. (NYSE:ZTS)

Dohj LLC bought a new stake in Zoetis Inc. (NYSE:ZTS) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,504 shares of the company’s stock, valued at approximately $408,000.

Several other large investors also recently added to or reduced their stakes in ZTS. Algert Global LLC boosted its holdings in Zoetis by 29.5% in the second quarter. Algert Global LLC now owns 1,924 shares of the company’s stock worth $334,000 after purchasing an additional 438 shares in the last quarter. Quarry LP boosted its stake in shares of Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Zoetis by 57.0% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 13,977 shares of the company’s stock valued at $2,423,000 after acquiring an additional 5,073 shares during the last quarter. AMF Tjanstepension AB raised its stake in shares of Zoetis by 23.4% in the 3rd quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock valued at $20,594,000 after acquiring an additional 20,001 shares in the last quarter. Finally, Czech National Bank lifted its holdings in Zoetis by 6.1% in the 3rd quarter. Czech National Bank now owns 92,291 shares of the company’s stock worth $18,032,000 after purchasing an additional 5,339 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Leerink Partners assumed coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. UBS Group started coverage on Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 target price for the company. Morgan Stanley dropped their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Stifel Nicolaus reduced their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $215.00.

Zoetis Trading Down 1.1 %

Shares of Zoetis stock opened at $170.81 on Friday. The company’s fifty day moving average price is $169.62 and its two-hundred day moving average price is $179.49. The firm has a market capitalization of $77.06 billion, a PE ratio of 32.11, a price-to-earnings-growth ratio of 2.70 and a beta of 0.89. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter last year, the company earned $1.36 EPS. Zoetis’s revenue was up 11.6% on a year-over-year basis. On average, analysts expect that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.17%. Zoetis’s dividend payout ratio is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.